Filter by
Safety of Favipiravir for Treatment of COVID-19: Latest Systematic Review
Adverse event studies of favipiravir used to treat COVID-19 have been ongoing since it was established as a treatment option. A better understanding of the side effects of favipiravir from recent studies is important for developing and assessing the introduction of effective treatments for COVID-19
- Edition
- -
- ISBN/ISSN
- -
- Collation
- -
- Series Title
- -
- Call Number
- -
Role of favipiravir in the treatment of COVID-19
The coronavirus disease-2019 (COVID-19) outbreak all over the world has led the researchers to strive to develop drugs or vaccines to prevent or halt the progression of this ailment. To hasten the treatment process, repurposed drugs are being evaluated. Favipiravir is one such oral drug that was approved for new and reemerging pandemic influenza in Japan in 2014 and has shown potent in vitro ac…
- Edition
- -
- ISBN/ISSN
- -
- Collation
- -
- Series Title
- -
- Call Number
- -
Interim report of the favipiravir (Avigan®) observational study.
The new coronavirus (SARS-CoV-2) was initially identified from patients with pneumonia of unknown cause in Hubei Province, People’s Republic of China in December 2019. The virus has since spread globally and infected over four and a half million people as of May 15, 2020. In Japan, over 16,000 have been infected, and over 800 of them have died from the new coronavirus infection (COVID-19)
- Edition
- -
- ISBN/ISSN
- -
- Collation
- -
- Series Title
- -
- Call Number
- -
Computer Science, Information & General Works 
Philosophy & Psychology 
Religion 
Social Sciences 
Language 
Pure Science 
Applied Sciences 
Art & Recreation 
Literature 
History & Geography